Yabao Pharmaceutical Group Co., Ltd (600351.SS)
CNY 5.83
(0.0%)
CNY 5.83
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.9 Billion | 2.71 Billion | 2.76 Billion | 2.6 Billion | 3.04 Billion | 2.91 Billion |
| Cost of Revenue | 1.24 Billion | 1.19 Billion | 1.07 Billion | 1.05 Billion | 1.1 Billion | 1.16 Billion |
| Gross Profit | 1.66 Billion | 1.51 Billion | 1.68 Billion | 1.54 Billion | 1.93 Billion | 1.75 Billion |
| Operating Expenses | 1.43 Billion | 1.3 Billion | 1.46 Billion | 1.38 Billion | 1.53 Billion | 1.37 Billion |
| Selling, General and Administrative Expenses | 1.02 Billion | 950.86 Million | 1.1 Billion | 1.03 Billion | 1.2 Billion | 1.02 Billion |
| Research and Development Expenses | 119.31 Million | 130.61 Million | 157.12 Million | 144.46 Million | 112.78 Million | 112.12 Million |
| Other Expenses | 289.39 Million | 222.74 Million | 205.17 Million | 198.83 Million | 220.42 Million | -898.57 Thousand |
| Cost and Expenses | 2.68 Billion | 2.5 Billion | 2.53 Billion | 2.44 Billion | 2.64 Billion | 2.54 Billion |
| Operating Income | 226.33 Million | 220.39 Million | 203.21 Million | 127.34 Million | 378.52 Million | 330.86 Million |
| Interest Expense | 12.29 Million | 18.76 Million | 22.6 Million | 32.6 Million | 48.03 Million | 34.83 Million |
| Income Tax Expense | 39.06 Million | 21.04 Million | 17.83 Million | 18.43 Million | 39.07 Million | 45.94 Million |
| Earnings before Tax | 218.98 Million | 125.64 Million | 201.59 Million | 127.41 Million | 49.87 Million | 329.96 Million |
| Net Income | 199.58 Million | 104.65 Million | 187.08 Million | 107.36 Million | 10.79 Million | 273.33 Million |
| Earnings Per Share Basic | 0.26 | 0.14 | 0.24 | 0.14 | 0.01 | 0.35 |
| Earnings Per Share Diluted | 0.26 | 0.14 | 0.24 | 0.14 | 0.01 | 0.35 |
| Weighted Average Shares Outstanding | 767.63 Million | 770 Million | 770 Million | 770 Million | 770 Million | 784.76 Million |
| Weighted Average Shares Outstanding (Diluted) | 763.23 Million | 770 Million | 770 Million | 770 Million | 770 Million | 784.76 Million |
| Gross Margin | 0.57 | 0.56 | 0.61 | 0.59 | 0.64 | 0.60 |
| EBIT Margin | 0.13 | 0.14 | 0.15 | 0.13 | 0.18 | 0.19 |
| Profit Margin | 0.07 | 0.04 | 0.07 | 0.04 | 0.00 | 0.09 |
| EBITDA | 391.76 Million | 309.67 Million | 398.74 Million | 338.39 Million | 284.16 Million | 515.57 Million |
| Earnings Before Tax Margin | 0.08 | 0.08 | 0.07 | 0.05 | 0.12 | 0.11 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 677.82 Million | 664.12 Million | 761.15 Million | 710.32 Million | 2.9 Billion | 666.6 Million |
| Cost of Revenue | 363.65 Million | 339.3 Million | 336.33 Million | 277.47 Million | 1.22 Billion | 293.42 Million |
| Gross Profit | 314.17 Million | 324.82 Million | 424.81 Million | 432.84 Million | 1.68 Billion | 373.18 Million |
| Operating Expenses | 240.42 Million | 259.97 Million | 299.47 Million | 356.84 Million | 1.35 Billion | 325.42 Million |
| Selling, General and Administrative Expenses | 402.37 Million | 219.46 Million | 268.22 Million | 119.82 Million | - | 401.69 Million |
| Research and Development Expenses | 21 Million | 34.75 Million | 31.01 Million | 33.71 Million | - | 32.77 Million |
| Other Expenses | -182.95 Million | -5.75 Million | -235.37 Thousand | -6.87 Million | -7.35 Million | -219.33 Thousand |
| Cost and Expenses | 604.07 Million | 599.27 Million | 635.8 Million | 634.32 Million | 2.58 Billion | 618.85 Million |
| Operating Income | 76.23 Million | 64.84 Million | 125.34 Million | -18.95 Million | 226.33 Million | 53.55 Million |
| Interest Expense | 1.04 Million | 1.78 Million | 1.83 Million | 1.56 Million | 12.29 Million | 2.36 Million |
| Income Tax Expense | 17.92 Million | 9.99 Million | 27.61 Million | 6.75 Million | 39.06 Million | 7.42 Million |
| Earnings before Tax | 71.2 Million | 75.44 Million | 137.48 Million | -25.83 Million | 218.98 Million | 53.33 Million |
| Net Income | 55.15 Million | 67.51 Million | 112.26 Million | -14.23 Million | 199.58 Million | 45.78 Million |
| Earnings Per Share Basic | 0.08 | 0.09 | 0.15 | -0.02 | - | 0.06 |
| Earnings Per Share Diluted | 0.08 | 0.09 | 0.15 | -0.02 | - | 0.06 |
| Weighted Average Shares Outstanding | 720 Million | 720 Million | 748.7 Million | 748.7 Million | 767.63 Million | 760 Million |
| Weighted Average Shares Outstanding (Diluted) | 720 Million | 720 Million | 748.7 Million | 748.7 Million | 767.63 Million | 760 Million |
| Gross Margin | 0.46 | 0.49 | 0.56 | 0.61 | 0.58 | 0.56 |
| EBIT Margin | 0.11 | 0.15 | 0.18 | 0.10 | - | 0.07 |
| Profit Margin | 0.08 | 0.10 | 0.15 | -0.02 | 0.07 | 0.07 |
| EBITDA | 72.24 Million | 100.45 Million | 140.29 Million | 70.53 Million | - | 49.15 Million |
| Earnings Before Tax Margin | 0.11 | 0.10 | 0.16 | -0.03 | 0.08 | 0.08 |
GE
ALMS
GAMB
E3B
4374
1137